|
 "We've been more than accommodating" in trying to set it up, the
White House official told Reuters on Monday, adding that they
couldn't get all the executives at the same time.
Politico had earlier reported
https://www.politico.com/news/
2020/07/27/drugmakers-trump-meeting-canceled-382847, citing industry
sources, that the discussion was called off because major drug
lobbies, reeling from a series of executive orders, refused to send
any members.
Trump on Friday https://in.reuters.com/article/usa-trump-drugprices/trump-signs-orders-to-lower-prescription-drug-prices-idINKCN24Q03X
signed four executive orders aimed at lowering the prices Americans
pay for prescription drugs, as he faces an uphill re-election battle
and criticism over his handling of the coronavirus pandemic.
(Reporting by Vishwadha Chander in Bengaluru, Steve Holland in
Washington D.C. and Carl O'Donnell in New York; Editing by Anil
D'Silva)
[to top of second column] |
The drug lobbies PhRMA and BIO were reluctant to send representatives from their
member companies after conflicting reports last week about whether the White
House would include the rule and little information to date about what the new
rule would look like, Politico reported.
Both, PhRMA and BIO said the president's plan to import policies from socialized
health care systems abroad would hinder the industry's efforts to fight the
COVID-19 pandemic.
While they oppose policies that would allow foreign governments to set prices
for medicines in the United States, the two lobbies said they were ready to
discuss ways to lower costs for prescription drugs.
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content. |
